儿童喘中的社会不平等
Angela Pinot de Moira1, Adnan Custovic1
1National Heart and Lung Institute, Imperial College London, London, United Kingdom.
The World Allergy Organization journal
|December 19, 2024
概括
处于不利社会经济环境 (SECs) 的儿童面临更高的儿童喘诊断风险和更差的喘结果. 需要进行研究,以了解途径,并减少这些健康不平等.
科学领域:
- 儿科过敏和免疫学
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 喘是一种常见的儿童慢性疾病,带来了相当大的医疗费用.
- 不利的社会经济环境 (SECs) 与儿童喘的不成比例负担有关.
- 了解喘中的社会不平等对于有效的公共卫生干预至关重要.
研究的目的:
- 审查处于不利地位的SEC与儿童喘风险和结果之间的关联.
- 探索喘亚型之间的地理变异和差异.
- 讨论将SEC与儿童喘及其结果联系起来的调解途径.
主要方法:
- 对现有关于社会经济地位和儿童喘的文献进行系统审查.
- 对喘患病率和结果的地理差异分析.
- 讨论潜在的生物,环境和社会介导因素.
主要成果:
- 在高收入国家 (HICs) 中,处于不利地位的SEC和儿童喘患病率增加之间存在一致的关联.
- 与处于不利地位的 SEC 相关的喘表型较少的形,更有可能从婴儿期开始.
- 处于不利地位的SEC与更糟糕的喘结果相关,低收入和中等收入国家 (LMICs) 的差异明显.
结论:
- 社会不平等显著影响儿童喘风险和结果.
- 将处于不利地位的SEC与喘联系在一起的途径是复杂的,需要进一步调查.
- 需要有针对性的干预措施来减少整个生命过程中与喘相关的健康差异.
相关概念视频
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Asthma: Pathogenesis and Management
348
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
348
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Other Pulmonary Disorders
803
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
803


